bmy 45778 has been researched along with l 158809 in 1 studies
Studies (bmy 45778) | Trials (bmy 45778) | Recent Studies (post-2010) (bmy 45778) | Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) |
---|---|---|---|---|---|
16 | 0 | 4 | 137 | 0 | 7 |
Protein | Taxonomy | bmy 45778 (IC50) | l 158809 (IC50) |
---|---|---|---|
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0015 | |
Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.0003 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0002 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0021 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meanwell, NA | 1 |
1 other study(ies) available for bmy 45778 and l 158809
Article | Year |
---|---|
Synopsis of some recent tactical application of bioisosteres in drug design.
Topics: Cytochrome P-450 Enzyme System; Drug Design | 2011 |